Tag Archives: AMRN

H.C. Wainwright Thinks Amarin’s Stock is Going to Recover

H.C. Wainwright analyst Andrew Fein maintained a Buy rating on Amarin (AMRN – Research Report) on March 31 and set a price target of $51.00. The company’s shares closed last Wednesday at $4.98, close to its 52-week low of $3.96.

What Made Oppenheimer Upgrade Amarin’s Stock?

Amarin (AMRN – Research Report) received a Hold rating from Oppenheimer analyst Leland Gershell today. The company’s shares closed last Monday at $13.58. According to TipRanks.com, Gershell is a 2-star analyst with an average return of 0.0% and a 39.8%

Amarin (AMRN) Gets a Hold Rating from Stifel Nicolaus

In a report released today, Derek Archila from Stifel Nicolaus reiterated a Hold rating on Amarin (AMRN – Research Report), with a price target of $24.00. The company’s shares closed last Monday at $15.09, close to its 52-week low of

Amarin (AMRN) Gets a Sell Rating from Oppenheimer

Oppenheimer analyst Leland Gershell maintained a Sell rating on Amarin (AMRN – Research Report) today and set a price target of $13.00. The company’s shares closed last Monday at $17.58. According to TipRanks.com, Gershell is a 5-star analyst with an

Tuesday’s Midday Movers: Mallinckrodt (MNK), Novavax (NVAX), Amarin (AMRN), Arrowhead Research (ARWR), Peabody Energy Comm (BTU)

So far Tuesday, January 21, NASDAQ is up 0.55% and the S&P is up 1.06%. Let’s take a look at this morning’s most active stocks and their recent analyst insights; Mallinckrodt (MNK – Research Report), Novavax (NVAX – Research Report),

Thursday’s Highlights at Noon: Goodrich Petroleum (GDP), Rite Aid (RAD), Aerie Pharma (AERI), Omeros (OMER), Amarin (AMRN)

So far Thursday, December 19, NASDAQ is up 1.09% and the S&P is up 0.89%. Here are this morning’s most active stocks: Goodrich Petroleum (GDP – Research Report), Rite Aid (RAD – Research Report), Aerie Pharma (AERI – Research Report),